DrGaP: A powerful tool for identifying driver genes and pathways in cancer sequencing studies

American Journal of Human Genetics

Volumn 93, Issue 3, 2013, Pages 439-451

  Hua, Xing ^a,b   Xu, Haiming ^a,c   Yang, Yaning ^b   Zhu, Jun ^c   Liu, Pengyuan ^a   Lu, Yan ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; CANCER GENETICS; COLORECTAL CANCER; DRGAP; DRIVER GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; LUNG ADENOCARCINOMA; OVARY CARCINOMA; PREVALENCE; PRIORITY JOURNAL; SIMULATION; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL;

BASE SEQUENCE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENES, NEOPLASM; HUMANS; MODELS, STATISTICAL; MUTATION; MUTATION RATE; NEOPLASMS; ROC CURVE; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 84883799242     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2013.07.003     Document Type: Article

References (57)

1. M.R. Stratton, P.J. Campbell, and P.A. Futreal The cancer genome Nature 458 2009 719 724
2. M. Meyerson, S. Gabriel, and G. Getz Advances in understanding cancer genomes through second-generation sequencing Nat. Rev. Genet. 11 2010 685 696
3. H. Yan, D.W. Parsons, G. Jin, R. McLendon, B.A. Rasheed, W. Yuan, I. Kos, I. Batinic-Haberle, S. Jones, and G.J. Riggins IDH1 and IDH2 mutations in gliomas N. Engl. J. Med. 360 2009 765 773
4. T.J. Ley, L. Ding, M.J. Walter, M.D. McLellan, T. Lamprecht, D.E. Larson, C. Kandoth, J.E. Payton, J. Baty, and J. Welch DNMT3A mutations in acute myeloid leukemia N. Engl. J. Med. 363 2010 2424 2433
5. X.J. Yan, J. Xu, Z.H. Gu, C.M. Pan, G. Lu, Y. Shen, J.Y. Shi, Y.M. Zhu, L. Tang, and X.W. Zhang Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia Nat. Genet. 43 2011 309 315
6. J.W. Harbour, M.D. Onken, E.D. Roberson, S. Duan, L. Cao, L.A. Worley, M.L. Council, K.A. Matatall, C. Helms, and A.M. Bowcock Frequent mutation of BAP1 in metastasizing uveal melanomas Science 330 2010 1410 1413
7. M. Bott, M. Brevet, B.S. Taylor, S. Shimizu, T. Ito, L. Wang, J. Creaney, R.A. Lake, M.F. Zakowski, and B. Reva The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma Nat. Genet. 43 2011 668 672
8. S. Jones, T.L. Wang, IeM. Shih, T.L. Mao, K. Nakayama, R. Roden, R. Glas, D. Slamon, L.A. Diaz Jr., and B. Vogelstein Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma Science 330 2010 228 231
9. K. Wang, J. Kan, S.T. Yuen, S.T. Shi, K.M. Chu, S. Law, T.L. Chan, Z. Kan, A.S. Chan, and W.Y. Tsui Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat. Genet. 43 2011 1219 1223
10. P. Van Vlierberghe, T. Palomero, H. Khiabanian, J. Van der Meulen, M. Castillo, N. Van Roy, B. De Moerloose, J. Philippé, S. González-García, and M.L. Toribio PHF6 mutations in T-cell acute lymphoblastic leukemia Nat. Genet. 42 2010 338 342
11. Y. Jiao, C. Shi, B.H. Edil, R.F. de Wilde, D.S. Klimstra, A. Maitra, R.D. Schulick, L.H. Tang, C.L. Wolfgang, and M.A. Choti DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 331 2011 1199 1203
12. M. Li, H. Zhao, X. Zhang, L.D. Wood, R.A. Anders, M.A. Choti, T.M. Pawlik, H.D. Daniel, R. Kannangai, and G.J. Offerhaus Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma Nat. Genet. 43 2011 828 829
13. L. Pasqualucci, V. Trifonov, G. Fabbri, J. Ma, D. Rossi, A. Chiarenza, V.A. Wells, A. Grunn, M. Messina, and O. Elliot Analysis of the coding genome of diffuse large B-cell lymphoma Nat. Genet. 43 2011 830 837
14. X. Wei, V. Walia, J.C. Lin, J.K. Teer, T.D. Prickett, J. Gartner, S. Davis, K. Stemke-Hale, M.A. Davies, J.E. Gershenwald NISC Comparative Sequencing Program Exome sequencing identifies GRIN2A as frequently mutated in melanoma Nat. Genet. 43 2011 442 446
15. T.D. Prickett, X. Wei, I. Cardenas-Navia, J.K. Teer, J.C. Lin, V. Walia, J. Gartner, J. Jiang, P.F. Cherukuri, and A. Molinolo Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma Nat. Genet. 43 2011 1119 1126
16. I. Varela, P. Tarpey, K. Raine, D. Huang, C.K. Ong, P. Stephens, H. Davies, D. Jones, M.L. Lin, and J. Teague Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
17. L. Ding, G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, and M.B. Morgan Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
18. G. Getz, H. Höfling, J.P. Mesirov, T.R. Golub, M. Meyerson, R. Tibshirani, and E.S. Lander Comment on "The consensus coding sequences of human breast and colorectal cancers" Science 317 2007 1500
19. C. Greenman, R. Wooster, P.A. Futreal, M.R. Stratton, and D.F. Easton Statistical analysis of pathogenicity of somatic mutations in cancer Genetics 173 2006 2187 2198
20. J. Lin, C.M. Gan, X. Zhang, S. Jones, T. Sjöblom, L.D. Wood, D.W. Parsons, N. Papadopoulos, K.W. Kinzler, and B. Vogelstein A multidimensional analysis of genes mutated in breast and colorectal cancers Genome Res. 17 2007 1304 1318
21. G. Parmigiani, and S. Chen TRAB: testing whether mutation frequencies are above an unknown background Stat. Appl. Genet. Mol. Biol. 7 2008 e11
22. T. Sjöblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, and N. Silliman The consensus coding sequences of human breast and colorectal cancers Science 314 2006 268 274
23. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjöblom, R.J. Leary, D. Shen, S.M. Boca, T. Barber, and J. Ptak The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113
24. A. Youn, and R. Simon Identifying cancer driver genes in tumor genome sequencing studies Bioinformatics 27 2011 175 181
25. D.W. Parsons, M. Li, X. Zhang, S. Jones, R.J. Leary, J.C. Lin, S.M. Boca, H. Carter, J. Samayoa, and C. Bettegowda The genetic landscape of the childhood cancer medulloblastoma Science 331 2011 435 439
26. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
27. W. Lee, Z. Jiang, J. Liu, P.M. Haverty, Y. Guan, J. Stinson, P. Yue, Y. Zhang, K.P. Pant, and D. Bhatt The mutation spectrum revealed by paired genome sequences from a lung cancer patient Nature 465 2010 473 477
28. E.D. Pleasance, P.J. Stephens, S. O'Meara, D.J. McBride, A. Meynert, D. Jones, M.L. Lin, D. Beare, K.W. Lau, and C. Greenman A small-cell lung cancer genome with complex signatures of tobacco exposure Nature 463 2010 184 190
29. M.A. Chapman, M.S. Lawrence, J.J. Keats, K. Cibulskis, C. Sougnez, A.C. Schinzel, C.L. Harview, J.-P. Brunet, G.J. Ahmann, and M. Adli Initial genome sequencing and analysis of multiple myeloma Nature 471 2011 467 472
30. G. Casella An introduction to empirical Bayes data analysis Am. Stat. 39 1985 83 97
31. S.B. Ng, E.H. Turner, P.D. Robertson, S.D. Flygare, A.W. Bigham, C. Lee, T. Shaffer, M. Wong, A. Bhattacharjee, and E.E. Eichler Targeted capture and massively parallel sequencing of 12 human exomes Nature 461 2009 272 276
32. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc., B 57 1995 289 300
33. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
34. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
35. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
36. M.C. Wendl, J.W. Wallis, L. Lin, C. Kandoth, E.R. Mardis, R.K. Wilson, and L. Ding PathScan: a tool for discerning mutational significance in groups of putative cancer genes Bioinformatics 27 2011 1595 1602
37. Z. Hu, C. Wu, Y. Shi, H. Guo, X. Zhao, Z. Yin, L. Yang, J. Dai, L. Hu, and W. Tan A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese Nat. Genet. 43 2011 792 796
38. D. Miki, M. Kubo, A. Takahashi, K.A. Yoon, J. Kim, G.K. Lee, J.I. Zo, J.S. Lee, N. Hosono, and T. Morizono Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations Nat. Genet. 42 2010 893 896
39. K.M. Zbuk, and C. Eng Cancer phenomics: RET and PTEN as illustrative models Nat. Rev. Cancer 7 2007 35 45
40. Y.S. Ju, W.C. Lee, J.Y. Shin, S. Lee, T. Bleazard, J.K. Won, Y.T. Kim, J.I. Kim, J.H. Kang, and J.S. Seo A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing Genome Res. 22 2012 436 445
41. T. Kohno, H. Ichikawa, Y. Totoki, K. Yasuda, M. Hiramoto, T. Nammo, H. Sakamoto, K. Tsuta, K. Furuta, and Y. Shimada KIF5B-RET fusions in lung adenocarcinoma Nat. Med. 18 2012 375 377
42. D. Lipson, M. Capelletti, R. Yelensky, G. Otto, A. Parker, M. Jarosz, J.A. Curran, S. Balasubramanian, T. Bloom, and K.W. Brennan Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies Nat. Med. 18 2012 382 384
43. K. Takeuchi, M. Soda, Y. Togashi, R. Suzuki, S. Sakata, S. Hatano, R. Asaka, W. Hamanaka, H. Ninomiya, and H. Uehara RET, ROS1 and ALK fusions in lung cancer Nat. Med. 18 2012 378 381
44. M. Colomiere, A.C. Ward, C. Riley, M.K. Trenerry, D. Cameron-Smith, J. Findlay, L. Ackland, and N. Ahmed Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas Br. J. Cancer 100 2009 134 144
45. B.D. Looyenga, D. Hutchings, I. Cherni, C. Kingsley, G.J. Weiss, and J.P. Mackeigan STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma PLoS ONE 7 2012 e30820
46. A.P. Costa-Pereira, N.A. Bonito, and M.J. Seckl Dysregulation of janus kinases and signal transducers and activators of transcription in cancer Am. J. Cancer Res. 1 2011 806 816
47. H.S. Jeon, and J. Jen TGF-beta signaling and the role of inhibitory Smads in non-small cell lung cancer J. Thorac. Oncol. 5 2010 417 419
48. Y. Gui, G. Guo, Y. Huang, X. Hu, A. Tang, S. Gao, R. Wu, C. Chen, X. Li, and L. Zhou Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder Nat. Genet. 43 2011 875 878
49. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, R.J. Li, C. Fakhry, T.X. Xie, J. Zhang, and J. Wang Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
50. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, A. Sivachenko, G.V. Kryukov, M.S. Lawrence, C. Sougnez, and A. McKenna The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
51. Y.G. Cho, X. Chang, I.S. Park, K. Yamashita, C. Shao, P.K. Ha, S.I. Pai, D. Sidransky, and M.S. Kim Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma Int. J. Oncol. 39 2011 337 344
52. E. Iorns, T.M. Ward, S. Dean, A. Jegg, D. Thomas, N. Murugaesu, D. Sims, C. Mitsopoulos, K. Fenwick, and I. Kozarewa Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor Breast Cancer Res. Treat. 135 2012 79 91
53. T. Chano, K. Ikebuchi, Y. Ochi, H. Tameno, Y. Tomita, Y. Jin, H. Inaji, M. Ishitobi, K. Teramoto, and I. Nishimura RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer PLoS ONE 5 2010 e11404
54. D.G. Miller On the nature of susceptibility to cancer. The presidential address Cancer 46 1980 1307 1318
55. M. Marty, F. Cognetti, D. Maraninchi, R. Snyder, L. Mauriac, M. Tubiana-Hulin, S. Chan, D. Grimes, A. Antón, and A. Lluch Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group J. Clin. Oncol. 23 2005 4265 4274
56. M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita North-East Japan Study Group Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N. Engl. J. Med. 362 2010 2380 2388
57. L. Zhang, S. Ma, X. Song, B. Han, Y. Cheng, C. Huang, S. Yang, X. Liu, Y. Liu, S. Lu INFORM investigators Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial Lancet Oncol. 13 2012 466 475